GGrantIndex
← Leaderboards

Ann K Rosenthal

Medical College Of Wisconsin

$2,594,551
Attributed
$3,552,940
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $494.8K · FY200525
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,552,940 · 3
VA$0 · 3

By mechanism

R01$3,552,940 · 3
I01$0 · 3

Top collaborators

Most similar at Medical College Of Wisconsin

Same institution · by research overlap

Others in their field

Top investigators on “Chondrocytes

Research focus

ChondrocytesArticular CartilageProteinsArthritisAffectElderlyRisk FactorsPainCalcium PyrophosphateCrystal FormationTissuesReportingAmericanPhenotypeJoint InjuryPathway InteractionsCalcium Pyrophosphate Deposition DiseaseMutationEffective TherapyPharmaceutical PreparationsCharacteristicsIn VitroVeteransExtracellular

Grant awards (29)

Molecular pathways of calcium pyrophosphate deposition disease$454,473
R01 · FY2025 · AG · contact PI
Mutations in Osteoprotegerin Cause Calcium Pyrophosphate Deposition Disease$0
I01 · FY2025 · VA · contact PI
Molecular pathways of calcium pyrophosphate deposition disease$484,743
R01 · FY2024 · AG · contact PI
Mutations in Osteoprotegerin Cause Calcium Pyrophosphate Deposition Disease$0
I01 · FY2024 · VA · contact PI
Molecular pathways of calcium pyrophosphate deposition disease$482,805
R01 · FY2023 · AG · contact PI
Mutations in Osteoprotegerin Cause Calcium Pyrophosphate Deposition Disease$0
I01 · FY2023 · VA · contact PI
Molecular pathways of calcium pyrophosphate deposition disease$494,758
R01 · FY2022 · AG · contact PI
Mutations in Osteoprotegerin Cause Calcium Pyrophosphate Deposition Disease$0
I01 · FY2022 · VA · contact PI
Mutations in Osteoprotegerin Cause Calcium Pyrophosphate Deposition Disease$0
I01 · FY2021 · VA · contact PI
Mutations in Osteoprotegerin Cause Calcium Pyrophosphate Deposition Disease$0
I01 · FY2020 · VA · contact PI
Mutations in Osteoprotegerin Cause Calcium Pyrophosphate Deposition Disease$0
I01 · FY2019 · VA · contact PI
ANK-dependent ATP efflux causes calcium pyrophosphate deposition in cartilage$0
I01 · FY2018 · VA · contact PI
ANK-dependent ATP efflux causes calcium pyrophosphate deposition in cartilage$0
I01 · FY2017 · VA · contact PI
ANK-dependent ATP efflux causes calcium pyrophosphate deposition in cartilage$0
I01 · FY2016 · VA · contact PI
ANK-dependent ATP efflux causes calcium pyrophosphate deposition in cartilage$0
I01 · FY2015 · VA · contact PI
Novel roles for articular cartilage vesicles in osteoarthritis$0
I01 · FY2014 · VA · contact PI
Novel roles for articular cartilage vesicles in osteoarthritis$0
I01 · FY2013 · VA · contact PI
Novel roles for articular cartilage vesicles in osteoarthritis$0
I01 · FY2012 · VA · contact PI
Novel roles for articular cartilage vesicles in osteoarthritis$0
I01 · FY2011 · VA · contact PI
Transglutaminase Promotes CPPD Disease in Aging Joints$191,153
R01 · FY2007 · AG · contact PI
Matrix proteins promote matrix vesicle mineralization$155,532
R01 · FY2007 · AR · contact PI
Transglutaminase Promotes CPPD Disease in Aging Joints$196,862
R01 · FY2006 · AG · contact PI
Matrix proteins promote matrix vesicle mineralization$160,177
R01 · FY2006 · AR · contact PI
Transglutaminase Promotes CPPD Disease in Aging Joints$201,600
R01 · FY2005 · AG
Matrix proteins promote matrix vesicle mineralization$164,032
R01 · FY2005 · AR
Transglutaminase Promotes CPPD Disease in Aging Joints$201,600
R01 · FY2004 · AG
TRANSGLUTAMINASE PROMOTES CPPD DISEASE IN AGING JOINTS$125,351
R01 · FY2002 · AG
TRANSGLUTAMINASE PROMOTES CPPD DISEASE IN AGING JOINTS$121,700
R01 · FY2001 · AG
TRANSGLUTAMINASE PROMOTES CPPD DISEASE IN AGING JOINTS$118,154
R01 · FY2000 · AG